Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease

J Endocrinol Invest. 1991 Mar;14(3):197-200. doi: 10.1007/BF03346788.

Abstract

We have measured alpha-MSH in plasma of normal subjects and subjects with various diseases of the pituitary-adrenocortical system using a radioimmunoassay with a sensitivity of 1.2 pmol/l. No alpha-MSH could be detected in plasma of normal subjects (n = 6), in plasma of patients with Addison's disease (n = 3), Nelson's syndrome (n = 2), bromocriptine responsive (n = 2) and unresponsive (n = 5) Cushing's disease and in plasma of psychiatric patients on chronic treatment with the dopamine antagonist haloperidol (n = 5). Plasma alpha-MSH remained undetectable in 2 patients with Cushing's disease after iv injection of 60 micrograms/kg haloperidol. In contrast, alpha-MSH was detectable in plasma of normal dogs (n = 2) and dogs with pituitary dependent hyperadrenocorticism (n = 2), whereas the iv injection of halo peridol was associated with a rise of plasma alpha-MSH. Thus we are unable to detect circulating alpha-MSH in man despite the use of a sensitive radioimmunoassay.

MeSH terms

  • Addison Disease / blood
  • Adrenocorticotropic Hormone / blood
  • Animals
  • Cushing Syndrome / blood*
  • Dogs
  • Haloperidol / therapeutic use
  • Humans
  • Mental Disorders / drug therapy
  • Nelson Syndrome / blood
  • Prolactin / blood
  • alpha-MSH / blood*

Substances

  • alpha-MSH
  • Adrenocorticotropic Hormone
  • Prolactin
  • Haloperidol